Uncategorized

Worth Watching Stocks: Integra LifeSciences Holdings Corporation (NASDAQ:IART) & Hawaiian Electric Industries, Inc. (NYSE:HE)

Integra LifeSciences Holdings Corporation (NASDAQ:IART)

Integra LifeSciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedic surgery, neurosurgery, reconstructive and general surgery. Integra’s orthopedic products include devices and implants for foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. Integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. Integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. Surgeons don’t have a minute to waste. They navigate a world of uncertainty while making thousands of decisions every day. These decisions directly affect patients – and surgeons.

Integra LifeSciences Holdings Corporation (NASDAQ:IART)’s Financial Overview

Integra LifeSciences Holdings Corporation (NASDAQ) surged 2.25% yesterday to close its trading session at $50.54. The company has 1 year Price Target of $57.47. Integra LifeSciences Holdings Corporation has 52-Week high of $67.5 and 52-Week Low of $42.14. The stock touched its 52-Week High on 67.50 and 52-Week Low on 42.14. The stock traded with the volume of 266463 shares yesterday. The firm shows the market capitalization of $4.28 Billion.

Integra LifeSciences Holdings Corporation (NASDAQ) reported its last quarterly earnings on 9/29/2018 where the firm reported its Actual EPS of $0.59/share against the analyst consensus estimate of $0.59/share. The difference between the actual and expected EPS is $0 a share with a surprise factor of 0%.

The firm is trading with SMA20 of 7.39 Percent, SMA50 of 6.79 Percent and SMA200 of -13.11 percent. Integra LifeSciences Holdings Corporation has P/S value of 2.94 while its P/B value stands at 3.15. Similarly, the company has Return on Assets of 2.5 percent, Return on Equity of 6.9 percent and Return on Investment of 5 Percent. The company shows Gross Margin and Operating Margin of 63.9 percent and 5.8 percent respectively.

The Stock currently has Analyst’ mean Recommendation of 2.4 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

The 16 analysts offering 12-month price forecasts for Integra LifeSciences Holdings Corp have a median target of 56.50, with a high estimate of 70.00 and a low estimate of 50.00. The median estimate represents a +11.79% increase from the last price of 50.54.

Integra LifeSciences Holdings Corporation is expected* to report earnings on 02/21/2019 before market open. The report will be for the fiscal Quarter ending Dec 2018. According to Zacks Investment Research, based on 9 analysts’ forecasts, the consensus EPS forecast for the quarter is $0.62. The reported EPS for the same quarter last year was $0.64.

Hawaiian Electric Industries, Inc. (NYSE:HE)

Hawaiian Electric Industries, Inc. is one of the largest public companies in Hawaii and provides essential energy and financial services to the communities of our island state through its subsidiaries, Hawaiian Electric Company, Maui Electric Company and Hawaii Electric Light Company, and American Savings Bank. Its unique combination of businesses provides HEI with an efficient capital structure and the resources to invest in the strategic growth of our companies while continuing our history of uninterrupted dividends to shareholders.

Hawaiian Electric Industries, Inc. (NYSE:HE)’s Financial Outlook

The 5 analysts offering 12-month price forecasts for Hawaiian Electric Industries Inc have a median target of 34.00, with a high estimate of 35.00 and a low estimate of 31.00. The median estimate represents a -9.77% decrease from the last price of 37.68.

Hawaiian Electric Industries, Inc. is expected* to report earnings on 02/15/2019 after market close. The report will be for the fiscal Quarter ending Dec 2018. According to Zacks Investment Research, based on 1 analysts’ forecasts, the consensus EPS forecast for the quarter is $0.47. The reported EPS for the same quarter last year was $0.43.

According to Zacks Investment Research, Hawaiian Electric Industries, Inc. has a Consensus Recommendation of 3.33. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).

The Stock declined -0.24% and closed its last trading session at $37.68. The company has the market capitalization of $4.1 Billion. The stock has 52-week high of $39.35 and 52-Week low of $32.1. The firm touched its 52-Week high on 39.35 and 52-Week low on 32.10. The company has volume of 341396 shares. The company has a total of 108.77 Million shares outstanding.

Hawaiian Electric Industries, Inc. (NYSE) in the last quarter reported its actual EPS of $0.6/share where the analyst estimated EPS was $0.62/share. The difference between the actual and Estimated EPS is $-0.02. This shows a surprise factor of -3.2 percent.

The company has YTD performance of 2.89 percent. Beta for Hawaiian Electric Industries, Inc. stands at 0.23 while its ATR (average true range) is 0.51. The company has Weekly Volatility of 1.27%% and Monthly Volatility of 1.44%%.

Hawaiian Electric Industries, Inc. has distance from 20-day Simple Moving Average (SMA20) of 2.49%, Distance from 50-Day Simple Moving Average of 1.66 percent and Distance from 200-Day Simple Moving Average of 5.71%.

The Company currently has ROA (Return on Assets) of 1.4 percent, Return on Equity (ROE) of 8.5 Percent and Return on Investment (ROI) of 5.9% with Gross margin of 12.1 percent and Operating & Profit margin of 12.6% and 6.5% respectively.